{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "BA.1",
      "BA.2",
      "COVID-19",
      "Omicron variant",
      "SARS-CoV-2",
      "vaccine",
      "viral load"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "35986484",
  "DateCompleted": {
    "Year": "2022",
    "Month": "10",
    "Day": "17"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "07",
    "Day": "26"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2022",
        "Month": "08",
        "Day": "29"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1002/jmv.28079"
    ],
    "Journal": {
      "ISSN": "1096-9071",
      "JournalIssue": {
        "Volume": "94",
        "Issue": "12",
        "PubDate": {
          "Year": "2022",
          "Month": "Dec"
        }
      },
      "Title": "Journal of medical virology",
      "ISOAbbreviation": "J Med Virol"
    },
    "ArticleTitle": "SARS-CoV-2 RNA load in nasopharyngeal specimens from outpatients with breakthrough COVID-19 due to Omicron BA.1 and BA.2.",
    "Pagination": {
      "StartPage": "5836",
      "EndPage": "5840",
      "MedlinePgn": "5836-5840"
    },
    "Abstract": {
      "AbstractText": [
        "This retrospective observational study compared severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA load in nasopharyngeal specimens (NPs) from patients with breakthrough coronavirus disease 2019 (COVID-19) caused by the Omicron BA.1 or BA.2 sublineages. The convenience sample was composed of 277 outpatients (176 female/112 male; median age, 48 years; range, 12-97) with breakthrough COVID-19 (n\u2009=\u2009130 due to BA.1 and n\u2009=\u2009147 due to BA.2). All participants had completed a full vaccination schedule and 56% had received a booster vaccine dose at the time of COVID-19 breakthrough microbiological diagnosis. NPs were collected within 7 days (median 2 days) after symptom onset. The TaqPath COVID-19 Combo Kit (Thermo Fisher Scientific) was used to estimate viral loads in NPs. Overall, viral RNA loads in NPs were comparable (p\u2009=\u20090.31) for BA.1 (median, 7.1 log<sub>10</sub> copies/ml; range, 2.7-10.6) and BA.2 (median, 7.5 log<sub>10</sub> copies/ml; range, 2.7-10.6), yet peak viral load appeared to be reached sooner for BA.2 than for BA.1 (Day 1 vs. Days 3-5; p\u2009=\u20090.002). Time elapsed since last vaccine dose had no significant impact on SARS-CoV-2 RNA loads in the upper respiratory tract (URT) for either BA.1 or BA.2. The data presented do not support that the transmissibility advantage of BA.2 over BA.1 is related to generation of higher viral loads in the URT early after infection."
      ],
      "CopyrightInformation": "\u00a9 2022 The Authors. Journal of Medical Virology published by Wiley Periodicals LLC."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain."
          }
        ],
        "LastName": "de Michelena",
        "ForeName": "Paula",
        "Initials": "P"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain."
          }
        ],
        "LastName": "Olea",
        "ForeName": "Beatriz",
        "Initials": "B"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain."
          }
        ],
        "LastName": "Torres",
        "ForeName": "Ignacio",
        "Initials": "I"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Joint Research Unit Infection and Public Health FISABIO-University of Valencia, Institute for Integrative Systems Biology (I2SysBio, UV-CSIC) and CIBER in Epidemiology and Public Health, Valencia, Spain."
          }
        ],
        "LastName": "Gonz\u00e1lez-Candelas",
        "ForeName": "Fernando",
        "Initials": "F"
      },
      {
        "Identifier": [
          "0000-0003-3010-4110"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain."
          },
          {
            "Identifier": [],
            "Affiliation": "Department of Microbiology, School of Medicine, University of Valencia, Valencia, Spain."
          }
        ],
        "LastName": "Navarro",
        "ForeName": "David",
        "Initials": "D"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Observational Study",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "J Med Virol",
    "NlmUniqueID": "7705876",
    "ISSNLinking": "0146-6615"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "COVID-19 Vaccines"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "RNA, Viral"
    }
  ],
  "SupplMeshList": [
    "COVID-19 breakthrough infections"
  ],
  "CommentsCorrectionsList": [
    {
      "RefSource": "J Med Virol. 2023 Jul;95(7):e28935",
      "PMID": "37491805"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "diagnosis"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "COVID-19 Vaccines"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Middle Aged"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Outpatients"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "RNA, Viral"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "SARS-CoV-2"
    }
  ],
  "CoiStatement": "The authors declare no conflict of interest."
}